Skip to main content

Breast Neoplasm Clinical Trials

Review the breast neoplasm clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 51-75 of 721

Avelumab with Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients with Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
Status: Active
Location: 13 locations
Enzalutamide, Enzalutamide with Mifepristone, and Treatment of Physician's Choice for the Treatment of Patients with AR-Positive Metastatic Triple-Negative or ER-Low Breast Cancer
Status: Active
Location: 12 locations
Trastuzumab Deruxtecan for the Treatment of HER2 Immunohistochemistry 0 Unresectable or Metastatic Breast Cancer
Status: Active
Location: 12 locations
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Status: Active
Location: 14 locations
Sacituzumab Govitecan plus Nivolumab, with or without Relatlimab, as Second-Line Treatment in Patients with PD-L1 Positive Unresectable or Metastatic Triple Negative Breast Cancer, SIMONE Trial
Status: Active
Location: 12 locations
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Status: Active
Location: 14 locations
Dose-Reduced Docetaxel with Cyclophosphamide for the Treatment of Vulnerable Older Women with Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
Status: Active
Location: 11 locations
Stereotactic Body Radiotherapy in Treating Patients with Oligometastatic Breast Cancer or Metastatic Non-small Cell Lung Cancer
Status: Active
Location: 11 locations
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
Status: Active
Location: 13 locations
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
Status: Active
Location: 11 locations
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Status: Active
Location: 13 locations
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Active
Location: 13 locations
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Status: Active
Location: 11 locations
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Status: Active
Location: 10 locations
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Status: Active
Location: 10 locations
Accelerated Partial Breast Irradiation before Surgery for the Treatment of Early Stage Breast Cancer
Status: Active
Location: 10 locations
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Status: Active
Location: 9 locations
Comparing Different Endocrine Therapies for Male Breast Cancer, ETHAN Trial
Status: Active
Location: 9 locations
Study of 3-Day Partial Breast Radiation Therapy for the Treatment of Stage I Breast Cancer
Status: Active
Location: 9 locations
A Study of SDX-7320 in Combination with Eribulin for the Treatment of Patients with Triple-Negative Breast Cancer, ARETHA Study
Status: Active
Location: 9 locations
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Status: Active
Location: 13 locations
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
Status: Active
Location: 9 locations
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
Status: Active
Location: 10 locations
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Status: Active
Location: 9 locations
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Status: Active
Location: 11 locations